First Do No Harm: Scientific Evidence Implicating Allopathic Vaccination

Abstract

Allopathic vaccination has many scientifically documented safety deficits that counteract well-publicised benefits. Thimerosal and aluminium, common ingredients in vaccines, can cause neurologic, immunologic and developmental harm. The pertussis vaccine has induced pertussis microorganisms associated with whooping cough to mutate and become more virulent. People vaccinated against pertussis can be asymptomatic carriers and transmitters of the disease, rendering herd immunity, or community immunity, unlikely. People vaccinated against measles can spread the disease to other fully vaccinated people. The MMR (measles-mumps-rubella) vaccine increases the probability of requiring emergency care. It also increases the risk of seizures and thrombocytopenia, a serious bleeding disorder. Infections experienced during childhood, such as measles, mumps and chickenpox, encourage normal development of the immune system in most children, offering protection against heart disease, strokes and cancer in adulthood. Vaccines—which are designed to prevent infections—increase cancer rates.

Keywords

vaccination - immunisation - thimerosal - pertussis - measles - MMR vaccine

• References

• 1 Gallagher CM, Goodman MS. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997–2002. J Toxicol Environ Health A 2010; 73 (24) 1665-1677
• 2 Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med (Maywood) 2003; 228 (6) 660-664
• 3 Verstraeten T, Davis R, Gu D , et al. Increased risk of developmental neurologic impairment after high exposure to thimerosal-containing vaccine in first month of life. Proceedings of the Epidemic Intelligence Service Annual Conference, vol. 49. Atlanta, GA: Centers for Disease Control and Prevention; April 2000. http://mercury-freedrugs.org/docs . Accessed 29 March 2016
• 4 Mrozek-Budzyn D, Majewska R, Kieltyka A, Augustyniak M. Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life. Neurotoxicol Teratol 2012; 34 (6) 592-597
• 5 Miller NZ. Miller's Review of Critical Vaccine Studies: 400 Important Scientific Papers Summarized for Parents and Researchers. Santa Fe, New Mexico: New Atlantean Press; 2016: 20 , 34, 35, 62, 90, 102, 228–247
• 6 Gherardi RK, Authier FJ. Macrophagic myofasciitis: characterization and pathophysiology. Lupus 2012; 21 (2) 184-189
• 7 Khan Z, Combadière C, Authier FJ , et al. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med 2013; 11: 99
• 8 Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. Lupus 2012; 21 (2) 223-230
• 9 Mooi FR, van Loo IH, van Gent M , et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009; 15 (8) 1206-1213
• 10 Lavine J, Broutin H, Harvill ET, Bjørnstad ON. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine 2010; 29 (1) 11-16
• 11 Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014; 111 (2) 787-792
• 12 De Serres G, Markowski F, Toth E , et al. Largest measles epidemic in North America in a decade—Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis 2013; 207 (6) 990-998
• 13 Rosen JB, Rota JS, Hickman CJ , et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis 2014; 58 (9) 1205-1210
• 14 Wilson K, Hawken S, Kwong JC , et al. Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis. PLoS ONE 2011; 6 (12) e27897
• 15 Vestergaard M, Hviid A, Madsen KM , et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 2004; 292 (3) 351-357
• 16 Miller E, Andrews N, Stowe J, Grant A, Waight P, Taylor B. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. Am J Epidemiol 2007; 165 (6) 704-709
• 17 Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus 2014; 23 (6) 554-567
• 18 Andrews N, Stowe J, Miller E, Taylor B. Post-licensure safety of the meningococcal group C conjugate vaccine. Hum Vaccin 2007; 3 (2) 59-63
• 19 Kubota Y, Iso H, Tamakoshi A ; JACC Study Group. Association of measles and mumps with cardiovascular disease: The Japan Collaborative Cohort (JACC) study. Atherosclerosis 2015; 241 (2) 682-686
• 20 Pesonen E, Andsberg E, Ohlin H , et al. Dual role of infections as risk factors for coronary heart disease. Atherosclerosis 2007; 192 (2) 370-375